Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Diabetes

Free Subscription 16.03.2026 1 Acta Ophthalmol 1 Am J Cardiol 2 Am J Epidemiol 2 Am J Kidney Dis 2 Am J Med 2 Angiology 1 Atherosclerosis 2 BMC Ophthalmol 7 Diabet Med 10 Diabetes 1 Diabetes Care 25 Diabetes Obes Metab 11 Diabetologia 1 Invest Ophthalmol Vis Sci 1 J Autoimmun 3 J Clin Endocrinol Metab 5 J Diabetes Complications 1 J Hypertens 1 J Nutr 1 Med J Aust 3 Metabolism 1 Ophthalmol Retina 2 Pediatr Diabetes 1 PLoS Med 9 PLoS One 1 Proc Natl Acad Sci U S A 1 Retina 2 Transplant Proc

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Ophthalmol

1. SKOLLERUD LM, Andersen JK, Dinesen S, Savarimuthu TR, et al
   Training and validation of an automated algorithm to differentiate no and minimal diabetic retinopathy from more severe stages in wide-field images.
   Acta Ophthalmol. 2026 Mar 9. doi: 10.1111/aos.70122.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

2. VERDOIA M, Zilio F, Gioscia R, Viola O, et al
   Prognostic Impact of Drug-Coated Balloons in Patients With Diabetes Mellitus: A Propensity-Matched Study.
   Am J Cardiol. 2023;206:73-78.
   PubMed         Abstract available
   
   

   
   Am J Epidemiol

3. AL IZZATI R, Pakpahan E
   Longitudinal pattern of multimorbidity in older adult population: latent transition analysis in 34 countries.
   Am J Epidemiol. 2026;195:653-663.
   PubMed         Abstract available
   
   
4. WANG T, Wang J, Song Z, Miller E, et al
   Caution in handling switchers in pharmacoepidemiologic studies estimating treatment effects: the example of dipeptidyl peptidase-4 inhibitors and inflammatory bowel disease.
   Am J Epidemiol. 2026;195:768-782.
   PubMed         Abstract available
   
   

   
   Am J Kidney Dis

5. MOTTL AK, Sawinski DL, Bjornstad P
   Kidney and Cardiovascular Protection in Diabetes: Beyond Diabetes Typology.
   Am J Kidney Dis. 2026 Mar 4:S0272-6386(26)00728.
   PubMed         Abstract available
   
   
6. MORTON JI, Carstensen B, McDonald SP, Polkinghorne KR, et al
   Trends in the Incidence of End-Stage Kidney Disease in Type 1 and Type 2 Diabetes in Australia, 2010-2019.
   Am J Kidney Dis. 2023;82:608-616.
   PubMed         Abstract available
   
   

   
   Am J Med

7. HANIF M, Nagarajan JS, Murphy R, Sah SP, et al
   Glucagon-Like Peptide-1 Receptor Agonist and Lupus Nephritis in Systemic Lupus Erythematosus with Type 2 Diabetes.
   Am J Med. 2026 Mar 9:S0002-9343(26)00146-4. doi: 10.1016/j.amjmed.2026.
   PubMed         Abstract available
   
   
8. DEEDWANIA P, Banga A
   Sodium-Glucose Cotransporter 1&2 Inhibitors in Heart Failure and Diabetes Mellitus: From Foundational Therapy to Emerging Frontiers.
   Am J Med. 2026 Mar 8:S0002-9343(26)00177-4. doi: 10.1016/j.amjmed.2026.
   PubMed         Abstract available
   
   

   
   Angiology

9. ERZURUM M, Felekoglu MA, Erol Algul NI, Tas A, et al
   Effect of SGLT2 Inhibitors on Atrial Electromechanical Delay in Patients with Type 2 Diabetes.
   Angiology. 2026 Mar 12:33197261427837. doi: 10.1177/00033197261427837.
   PubMed         Abstract available
   
   
10. KARAASLAN H, Inan H, Elmas AN
    The Association Between Epicardial Adipose Tissue Thickness and the Triglyceride-glucose Index in Prediabetic Obese Patients.
    Angiology. 2026;77:498-506.
    PubMed         Abstract available
    
    

    
    Atherosclerosis

11. BONILHA I, Yoshinaga MY, Chaves-Filho AB, Gomes EIL, et al
    LDL subspecies and lipidome change by evolocumab add-on therapy to empagliflozin in patients with type 2 diabetes: A prespecified secondary analysis of a randomized clinical trial.
    Atherosclerosis. 2026;415:120686.
    PubMed         Abstract available
    
    

    
    BMC Ophthalmol

12. DENG C, Reddy K, Liang Y, Bommakanti N, et al
    Quantifying changes in retinal non-perfusion over time with ultra-widefield fluorescein angiography following intravitreal treatment of diabetic retinopathy.
    BMC Ophthalmol. 2026 Mar 9. doi: 10.1186/s12886-026-04708.
    PubMed         Abstract available
    
    
13. DOGAN I, Caglar C, Gursoy A, Kayadibi H, et al
    Serum and urinary mindin as a potential biomarker for diabetic retinopathy: a prospective cross-sectional study.
    BMC Ophthalmol. 2026 Mar 7. doi: 10.1186/s12886-026-04702.
    PubMed        
    
    

    
    Diabet Med

14. SOHOLM U, Holmes-Truscott E, Amiel SA, de Galan B, et al
    Assessing thoughts, feelings and behaviours related to hypoglycaemia: Psychometric evaluation of the Hypoglycaemia Cues Questionnaire (HypoC-Q).
    Diabet Med. 2026;43:e70231.
    PubMed         Abstract available
    
    
15. SHACHAM EC, Sharif S, Tatoor R, Ayalon S, et al
    Prevalence and outcomes of DKA in type 1 and type 2 DM patients treated and not treated with SGLT-2 inhibitors.
    Diabet Med. 2026;43:e70237.
    PubMed         Abstract available
    
    
16. NARAYANAN S, Baker J, Welsh JB, Cappon G, et al
    Feasibility and benefits of continuous glucose monitoring for type 1 diabetes in Rwanda: A real-world 12-month continuation phase.
    Diabet Med. 2026 Mar 9:e70284. doi: 10.1111/dme.70284.
    PubMed         Abstract available
    
    
17. BENTON M, Goldsmith K, Ching SM, Forbes A, et al
    A mobile phone application for the prevention of type 2 diabetes in Malaysian women with gestational diabetes mellitus (MYGODDESS): A feasibility randomised controlled trial.
    Diabet Med. 2026 Mar 10:e70257. doi: 10.1111/dme.70257.
    PubMed         Abstract available
    
    
18. WANG MJ, Zhao XY, Lu GH, Sun XC, et al
    Wnt inhibitory factor 1 inhibits glycolysis through the HIF1alpha/PFKFB3 signalling pathway to regulate macrophage polarization and alleviate diabetic retinopathy.
    Diabet Med. 2026 Mar 11:e70285. doi: 10.1111/dme.70285.
    PubMed         Abstract available
    
    
19. ROBERSON N, Holmes-Truscott E, Skinner TC, Halliday J, et al
    Shifting the narrative from 'what's wrong?' to 'what's strong?' MIND-MAP: A qualitative study exploring positive mental health and support needs of adults with diabetes.
    Diabet Med. 2026 Mar 12:e70273. doi: 10.1111/dme.70273.
    PubMed         Abstract available
    
    
20. TONG W, Liu T
    MiR-10a-5p aggravates podocyte injury in diabetic nephropathy by inhibiting E2f7-mediated autophagy.
    Diabet Med. 2026 Mar 12:e70270. doi: 10.1111/dme.70270.
    PubMed         Abstract available
    
    

    
    Diabetes

21. ZHANG W, Zhang L, Zhu J, Xiao C, et al
    Additional Evidence for the Relationship Between Type 2 Diabetes and Stroke Through Observational and Genetic Analyses.
    Diabetes. 2023;72:1671-1681.
    PubMed         Abstract available
    
    
22. LAI KZH, Semnani-Azad Z, Boucher BA, Retnakaran R, et al
    Association of Serum Very-Long-Chain Saturated Fatty Acids With Changes in Insulin Sensitivity and beta-Cell Function: The Prospective Metabolism and Islet Cell Evaluation (PROMISE) Cohort.
    Diabetes. 2023;72:1664-1670.
    PubMed         Abstract available
    
    
23. THIRAWATANANOND P, Brown ME, Sachs LK, Arnoletti JM, et al
    Treg-Specific CD226 Deletion Reduces Diabetes Incidence in NOD Mice by Improving Regulatory T-Cell Stability.
    Diabetes. 2023;72:1629-1640.
    PubMed         Abstract available
    
    
24. RUSS-SILSBY J, Patel KA, Laver TW, Hawkes G, et al
    The Role of ONECUT1 Variants in Monogenic and Type 2 Diabetes Mellitus.
    Diabetes. 2023;72:1729-1734.
    PubMed         Abstract available
    
    
25. SONG L, Chang X, Hu L, Liu L, et al
    Accelerating Wound Closure With Metrnl in Normal and Diabetic Mouse Skin.
    Diabetes. 2023;72:1692-1706.
    PubMed         Abstract available
    
    
26. LI Z, Guan L, Mu T, Zhou H, et al
    ANGPTL4 Induces Aberrant Lymphatic-Like Remodeling in Proliferative Diabetic Retinopathy.
    Diabetes. 2026 Mar 10:db250445. doi: 10.2337/db25-0445.
    PubMed         Abstract available
    
    
27. VERCALSTEREN E, Karampatsi D, Neicu M, Romanitan MO, et al
    Normalization of Insulin Resistance, Rather Than Hyperglycemia, Before Stroke Improves Functional Outcomes in a Mouse Model of Type 2 Diabetes.
    Diabetes. 2026 Mar 10:db250532. doi: 10.2337/db25-0532.
    PubMed         Abstract available
    
    
28. NJEIM R, Alkhansa S, Almoussawi S, Slika A, et al
    Mesenchymal Stem Cell and Secretome Treatments Inhibit the mTOR-NOX4 Pathway in Diabetic Kidney Disease.
    Diabetes. 2026 Mar 11:db251036. doi: 10.2337/db25-1036.
    PubMed         Abstract available
    
    
29. SAKAKI K, Murakami T, Yoshida H, Otani D, et al
    Quantitative beta-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes.
    Diabetes. 2026 Mar 12:db251127. doi: 10.2337/db25-1127.
    PubMed         Abstract available
    
    
30. BURTON JJN, Castro TA, Juray AA, Hassan HA, et al
    Sex-Dependent Diabetes Impact of Acute Grp78 Deletion in beta-Cells of Adult Mice.
    Diabetes. 2026 Mar 12:db250809. doi: 10.2337/db25-0809.
    PubMed         Abstract available
    
    

    
    Diabetes Care

31. BRUTTOMESSO D, Petrie JR, Evans M, Fleming GA, et al
    Challenges in and Opportunities for Individualizing Diabetes Technology: A Position Statement by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.
    Diabetes Care. 2026 Mar 12:dci260018. doi: 10.2337/dci26-0018.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

32. PANDEY A, Repetto E, Perkins C, Rossing P, et al
    Association Between Off-Label Use of Cardio-Kidney-Metabolic Therapies and Risk of Cardiovascular Events in Type 1 Diabetes: A Real-World Evidence Study.
    Diabetes Obes Metab. 2026 Mar 9. doi: 10.1111/dom.70597.
    PubMed        
    
    
33. RISI R, Pauletto D, Zanghi Buffi V, Berna V, et al
    The Burden of Obesity and Type 1 Diabetes: Distinct and Synergistic Effects to Worsen Perceived Health and Psychosocial Distress.
    Diabetes Obes Metab. 2026 Mar 9. doi: 10.1111/dom.70629.
    PubMed         Abstract available
    
    
34. BOCHANEN N, Vanlaer Y, Minschart C, Willems M, et al
    The One-Hour Oral Glucose Tolerance Test to Predict Glucose Intolerance Postpartum in Women With Prior Gestational Diabetes.
    Diabetes Obes Metab. 2026 Mar 9. doi: 10.1111/dom.70634.
    PubMed         Abstract available
    
    
35. FALCETTA P, Zilich R, Baccetti F, Baronti W, et al
    Identifying Predictors of Early Treatment Intensification in Individuals With Type 2 Diabetes Treated With GLP-1 Receptor Agonists: A Machine Learning-Based Analysis of a Large Real World Cohort.
    Diabetes Obes Metab. 2026 Mar 9. doi: 10.1111/dom.70648.
    PubMed         Abstract available
    
    
36. PAUL RG, Matuoka JY, Alshannaq HA, Pollock RF, et al
    Cost-effectiveness analysis of Dexcom ONE+ real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with type 2 diabetes in Aotearoa New Zealand.
    Diabetes Obes Metab. 2026 Mar 9. doi: 10.1111/dom.70593.
    PubMed         Abstract available
    
    
37. HUANG YM, Guo X, Chen JJ, Liu Z, et al
    Equivalent Acute Anti-Inflammatory Effects of Exercise in Type 2 Diabetes Versus Healthy Adults: A Randomised Crossover Study.
    Diabetes Obes Metab. 2026 Mar 10. doi: 10.1111/dom.70646.
    PubMed         Abstract available
    
    
38. POLJO A, Reichl JJ, Kollmann L, Kalinowski P, et al
    Type 2 diabetes subphenotypes are associated with differential outcomes after metabolic and bariatric surgery: An international multicentre retrospective cohort study.
    Diabetes Obes Metab. 2026 Mar 8. doi: 10.1111/dom.70547.
    PubMed         Abstract available
    
    
39. VESSARI H, Prami T, Peltonen EJ, Pimia E, et al
    Demographic Change in Prevalent Type 1 Diabetes Adult Population, and Association of Risk Factors With Comorbidities and Mortality-Results From the Finnish Diabetes Control Study FinDiCon.
    Diabetes Obes Metab. 2026 Mar 9. doi: 10.1111/dom.70641.
    PubMed         Abstract available
    
    
40. HUSSAIN S, Tree T, Mathieu C, Klupa T, et al
    An international consensus on screening and monitoring early-stage type 1 diabetes: A roadmap to European implementation.
    Diabetes Obes Metab. 2026 Mar 12. doi: 10.1111/dom.70569.
    PubMed         Abstract available
    
    
41. CARAMORI ML, Repetto E, Perkins C, Pandey A, et al
    Cardio-Kidney-Metabolic Therapy Use Among Adults With Type 1 Diabetes and Chronic Kidney Disease.
    Diabetes Obes Metab. 2026 Mar 12. doi: 10.1111/dom.70640.
    PubMed         Abstract available
    
    
42. ZHENG J, An Y, Zhang X, Cao Z, et al
    Serum Short-Chain Fatty Acid Profiles as Metabolic Signatures of Diabetic Cognitive Impairment: Multinomial Modelling and Internally Validated Multiclass Discrimination.
    Diabetes Obes Metab. 2026 Mar 12. doi: 10.1111/dom.70656.
    PubMed         Abstract available
    
    
43. SCHIMENES BC, Alvarenga TA, Tufik SB, Tufik S, et al
    Subjective Sleep Measures May Underestimate Fasting-Related Effects in Insulin-Treated Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Mar 12. doi: 10.1111/dom.70651.
    PubMed        
    
    
44. GHAZY RM, Alsaleem SA, Alshaikh AA, Al-Qahtani FS, et al
    Epidemiological Transition and Forecasting of Diabetes Burden in Saudi Arabia: A Comprehensive Analysis From the Global Burden of Disease Study 1990-2023.
    Diabetes Obes Metab. 2026 Mar 11. doi: 10.1111/dom.70650.
    PubMed        
    
    
45. RAM S, Corbin M, 't Mannetje A, Douwes J, et al
    Antibiotic Exposure in Early Life and Risk of Type 1 Diabetes: A Meta-Analysis.
    Diabetes Obes Metab. 2026 Mar 11. doi: 10.1111/dom.70636.
    PubMed         Abstract available
    
    
46. PHAM TP, Vo TM, Nguyen TA, Dao TP, et al
    Relative Efficacy of Next-Generation Incretin Therapies for Cardio-Renal Protection in Type 2 Diabetes: Evidence From a Network Meta-Analysis.
    Diabetes Obes Metab. 2026 Mar 10. doi: 10.1111/dom.70635.
    PubMed         Abstract available
    
    
47. AZAM MH, Azam MH, Azam KU, Azam MA, et al
    Efficacy and Safety of Mazdutide in Managing Overweight and Obesity Among Non-Diabetic Adults: A Meta-Analysis of Randomised Controlled Trials.
    Diabetes Obes Metab. 2026 Mar 10. doi: 10.1111/dom.70643.
    PubMed         Abstract available
    
    
48. GUO X, Long T, Peng L, Zhang Y, et al
    Spillover effects of a nudge-based dietary intervention on physical activity and sleep among adults with type 2 diabetes: Evidence from a randomised controlled trial.
    Diabetes Obes Metab. 2026 Mar 10. doi: 10.1111/dom.70592.
    PubMed         Abstract available
    
    
49. ZHOU J, Hu C, Chen J, Liu J, et al
    Artificial Intelligence in Screening and Grading Diabetic Eye Diseases: A Systematic Review From Algorithms to Clinic.
    Diabetes Obes Metab. 2026 Mar 8. doi: 10.1111/dom.70621.
    PubMed         Abstract available
    
    
50. JOSHI D, Rafiq T, Pigeyre M, de Mutsert R, et al
    Circulating Rhythmic Metabolites and Causal Risk of Type 2 Diabetes in Adults in the Canadian Longitudinal Study on Aging.
    Diabetes Obes Metab. 2026 Mar 8. doi: 10.1111/dom.70616.
    PubMed         Abstract available
    
    
51. SOUZA M
    Excessive Intrapancreatic Fat Deposition: A Missing Metabolic Driver of Pancreatic Carcinogenesis in Type 2 Diabetes?
    Diabetes Obes Metab. 2026 Mar 8. doi: 10.1111/dom.70645.
    PubMed        
    
    
52. GUARNOTTA V, Panto F, Vigneri E, Piombo G, et al
    Teplizumab in Stage 2 Type 1 Diabetes: Clinical Practice Experience on Feasibility in 3 Adult Patients.
    Diabetes Obes Metab. 2026 Mar 8. doi: 10.1111/dom.70626.
    PubMed         Abstract available
    
    
53. POPOVIC DS, Koufakis T, Vas PRJ, Del Prato S, et al
    Reframing Diabetes Mellitus as a Multiaxial Disease Continuum: The Diabetes Severity Classification (DSC) Framework.
    Diabetes Obes Metab. 2026 Mar 9. doi: 10.1111/dom.70631.
    PubMed         Abstract available
    
    
54. WANG R, Zhang Y, Gao Y, Chen L, et al
    Estimated Glucose Disposal Rate and Risk of Vascular Events and Death in Type 2 Diabetes in the ADVANCE Study.
    Diabetes Obes Metab. 2026 Mar 9. doi: 10.1111/dom.70608.
    PubMed         Abstract available
    
    
55. NOBAYASHI H, Satoh M, Hirose T, Nakayama S, et al
    Comparison of SGLT2 Inhibitors for New-Onset Proteinuria Risk in Patients With Type 2 Diabetes and Preserved Kidney Function.
    Diabetes Obes Metab. 2026 Mar 9. doi: 10.1111/dom.70625.
    PubMed         Abstract available
    
    
56. GUERCI B, Blanc-Bisson C, Vicaut E, De Pouvourville G, et al
    Economic burden of type 2 diabetes management in France according to clinical characteristics.
    Diabetes Obes Metab. 2026 Mar 9. doi: 10.1111/dom.70586.
    PubMed         Abstract available
    
    

    
    Diabetologia

57. POWE CE, White F, Allard C, Shook L, et al
    Placental expression of GKN1 and diminished pancreatic beta cell function during pregnancy.
    Diabetologia. 2026;69:1060-1066.
    PubMed         Abstract available
    
    
58. YAJNIK CS, Bandyopadhyay S, Bhat DS, Wagh RSH, et al
    Gestational glycaemia reflects lifelong glycaemia: the Pune Maternal Nutrition Study.
    Diabetologia. 2026;69:930-941.
    PubMed         Abstract available
    
    
59. JUMENTIER B, Qu HQ, Lu T, Liu K, et al
    Development and validation of a trans-ancestry polygenic risk score for type 1 diabetes.
    Diabetologia. 2026 Mar 7. doi: 10.1007/s00125-026-06706.
    PubMed         Abstract available
    
    
60. HUMBERT A, Nawrot M, Bendridi N, Gouriou Y, et al
    Endoplasmic reticulum-mitochondria contact sites are signalling hubs connecting nutrient sensing and GLP-1 secretion in L cells of the mouse gut: from physiology to obesity and type 2 diabetes.
    Diabetologia. 2026 Mar 8. doi: 10.1007/s00125-026-06693.
    PubMed         Abstract available
    
    
61. DE ALMEIDA ME, Ortenblad N, Platz AB, Petersen MH, et al
    Mitochondrial cristae density is increased following high-intensity interval training in men with type 2 diabetes.
    Diabetologia. 2026 Mar 8. doi: 10.1007/s00125-026-06694.
    PubMed         Abstract available
    
    
62. CUNNINGHAM HA, Ward L, Butler MP, Valent AM, et al
    Early meal timing improves nocturnal glucose in pregnancies complicated by gestational diabetes.
    Diabetologia. 2026 Mar 9. doi: 10.1007/s00125-026-06701.
    PubMed         Abstract available
    
    
63. CARR ALJ, Sutton H, Agesen RM, Bonifacio E, et al
    Continuous glucose monitoring as a tool in early-stage type 1 diabetes.
    Diabetologia. 2026 Mar 9. doi: 10.1007/s00125-026-06707.
    PubMed         Abstract available
    
    
64. EVANS-MOLINA C, Gitelman SE, Mari A, Ferrannini E, et al
    Beta cell glucose sensitivity identifies clinical response to disease-modifying therapies initiated at stage 3 type 1 diabetes onset.
    Diabetologia. 2026 Mar 12. doi: 10.1007/s00125-026-06703.
    PubMed         Abstract available
    
    
65. CAO J, Liu F, Kong H, Lai C, et al
    Integrated intraocular-plasma proteomics reveals conserved biomarkers for diabetic retinopathy progression: a multi-fluid biopsy study.
    Diabetologia. 2026 Mar 12. doi: 10.1007/s00125-026-06708.
    PubMed         Abstract available
    
    
66. CHIRIACO M, Trico D, Giannoni A, Sacchetta L, et al
    Impact of canagliflozin on the cardiorenal effects of dietary sodium intake in type 2 diabetes: a post hoc analysis of the CREDENCE trial.
    Diabetologia. 2026 Mar 12. doi: 10.1007/s00125-026-06705.
    PubMed         Abstract available
    
    
67. BRUTTOMESSO D, Petrie JR, Evans M, Fleming GA, et al
    Challenges in and opportunities for individualising diabetes technology: a position statement by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.
    Diabetologia. 2026 Mar 12. doi: 10.1007/s00125-025-06651.
    PubMed         Abstract available
    
    

    
    Invest Ophthalmol Vis Sci

68. WANG E, Feng B, Chen S, Wang H, et al
    Silencing of lncRNA HOTAIR Using Eyedrops as a Potential Treatment for Diabetes-Associated Retinal Dysregulation and Dysfunction.
    Invest Ophthalmol Vis Sci. 2026;67:24.
    PubMed         Abstract available
    
    

    
    J Autoimmun

69. MOSCOVITZ K, Bhavsar D, Tremlett H
    Interventional studies targeting the prodromal or preclinical phase of immune-mediated disease to benefit patient outcomes: a scoping review.
    J Autoimmun. 2026;159:103526.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

70. DELLA ROSA PA, Pecco N, Calloni SF, Canini M, et al
    Multimodal MRI Neurodevelopmental Profiling in Type 1 Diabetes: Long-term Effects of MDI vs CSII Treatments.
    J Clin Endocrinol Metab. 2026 Mar 7:dgag102. doi: 10.1210.
    PubMed         Abstract available
    
    
71. VAZQUEZ L, Arreola EV, Nagul M, Krakoff J, et al
    Comparing Surrogate Indexes for Insulin Resistance as Predictors of Type 2 Diabetes (T2D).
    J Clin Endocrinol Metab. 2026 Mar 10:dgag101. doi: 10.1210.
    PubMed         Abstract available
    
    
72. ALLEN LA, Taylor PN, Carlsson A, Fraser DP, et al
    Relative maternal protection against type 1 diabetes: a combined analysis of five observational studies.
    J Clin Endocrinol Metab. 2026 Mar 10:dgag103. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

73. BORDERIE G, Foussard N, Larroumet A, Blanco L, et al
    The skin autofluorescence of advanced glycation end-products relates to the development of foot ulcers in type 2 diabetes: A longitudinal observational study.
    J Diabetes Complications. 2023;37:108595.
    PubMed         Abstract available
    
    
74. PEDERSEN FN, Stokholm L, Andersen N, Andresen J, et al
    Longitudinal bidirectional associations between diabetic retinopathy and diagnosed depression: Results from a Danish nationwide registry-based cohort study.
    J Diabetes Complications. 2023;37:108589.
    PubMed         Abstract available
    
    
75. HERMANYI Z, Csiki V, Menyhart A, Osgyan K, et al
    How to evaluate over 60 million blood glucose data - The design of the MERY Diabetes Database.
    J Diabetes Complications. 2023;37:108586.
    PubMed         Abstract available
    
    
76. TOUGAARD NH, Hansen TW, Rossing P
    Vitamin D deficiency and development of complications in individuals with type 1 and type 2 diabetes: A cohort study.
    J Diabetes Complications. 2023;37:108611.
    PubMed         Abstract available
    
    
77. ZHOU Q, Tang H, Li S
    Protective effect of evolocumab on Muller cells in the rat retina under hyperglycaemic and hypoxic conditions.
    J Diabetes Complications. 2023;37:108593.
    PubMed         Abstract available
    
    

    
    J Hypertens

78. ANTZA C, Jordan J, McGowan B, Ciudin A, et al
    Treating obesity and heart failure: a how-to-manage guide from the European Association for the Study of obesity and the European Society of Hypertension working group on diabetes and metabolic risk factors.
    J Hypertens. 2026 Mar 10. doi: 10.1097/HJH.0000000000004285.
    PubMed         Abstract available
    
    

    
    J Nutr

79. ZHANG X, Ou Y, Li L, Wan Z, et al
    Associations of Nut Consumption with All-Cause Mortality among Individuals with Type 2 Diabetes.
    J Nutr. 2023;153:3003-3011.
    PubMed         Abstract available
    
    

    
    Med J Aust

80. O'BEIRNE J, Skoien R, Leggett BA, Hartel GF, et al
    Diabetes mellitus and the progression of non-alcoholic fatty liver disease to decompensated cirrhosis: a retrospective cohort study.
    Med J Aust. 2023;219:358-365.
    PubMed         Abstract available
    
    

    
    Metabolism

81. SONG E, Hwang SY, Park MJ, Jang A, et al
    Additive impact of diabetes and sarcopenia on all-cause and cardiovascular mortality: A longitudinal nationwide population-based study.
    Metabolism. 2023;148:155678.
    PubMed         Abstract available
    
    
82. ALABDULJABBAR K, le Roux CW
    Pharmacotherapy before and after bariatric surgery.
    Metabolism. 2023;148:155692.
    PubMed         Abstract available
    
    
83. ATABAKI NN, Coral DE, Pomares-Millan H, Smith K, et al
    A biological-systems-based analysis using proteomic and metabolic network inference reveals mechanistic insights into hepatic steatosis.
    Metabolism. 2026;178:156552.
    PubMed         Abstract available
    
    

    
    Ophthalmol Retina

84. CHANG AY, Yu Y, Cardillo S, Hubbard RA, et al
    Trends in Prevalence and Incidence of Diabetic Retinal Disease Across Age Cohorts.
    Ophthalmol Retina. 2026 Mar 9:S2468-6530(26)00104.
    PubMed         Abstract available
    
    

    
    Pediatr Diabetes

85. STANKUTE I, Marciulionyte D, Ostrauskas R, Cemerkaite A, et al
    Epidemiological Trends and Seasonal Patterns in Childhood Type 1 Diabetes: Insights From 2001 to 2024 in Lithuania.
    Pediatr Diabetes. 2026;2026:9968982.
    PubMed         Abstract available
    
    
86. CRAVEN M, Bamba V, Calabria AC, Pinney SE, et al
    Pediatric Hepatocyte Nuclear Factor 1B (HNF1B) Disease: Diabetes and Endocrine Manifestations.
    Pediatr Diabetes. 2025;2025:4077604.
    PubMed         Abstract available
    
    

    
    PLoS Med

87. SHAO SC, Tsai DH, Chuang AT, Liu KH, et al
    SGLT2 inhibitors, GLP-1 RAs, and DPP4 inhibitors and the risk of hypomagnesemia in type 2 diabetes: A target trial emulation.
    PLoS Med. 2026;23:e1004968.
    PubMed         Abstract available
    
    

    
    PLoS One

88. DIMNJAKOVIC J, Buble T, Poljicanin T, Brborovic H, et al
    Identifying high-risk combinations of metformin during COVID-19.
    PLoS One. 2026;21:e0343979.
    PubMed         Abstract available
    
    
89. ANAND S, Aggarwal D, Zaidi S, Kaushik H, et al
    Correction: Estimation of cervicocephalic kinesthetic perception and its correlation with fall risk in adults with diabetes and without diabetes experiencing cervical pain: A comparative study.
    PLoS One. 2026;21:e0344597.
    PubMed         Abstract available
    
    
90. 
    Correction: Prevalence of peripheral arterial disease and arterial calcification based on three ankle-brachial index calculation methods (highest, average, and lowest systolic ankle pressure): A cross-sectional study in Type 2 diabetes mellitus patien
    PLoS One. 2026;21:e0344591.
    PubMed         Abstract available
    
    
91. MULLER R, Muller D, Plonne D
    Comparison of glucose concentrations in simultaneously collected plasma and serum samples from outpatients in a routine laboratory setting.
    PLoS One. 2026;21:e0344562.
    PubMed         Abstract available
    
    
92. MESQUITA LO, Dos Santos DF, de Carvalho KMB
    Effect of COVID-19 on mortality due to diabetes mellitus in Brazil: A time series analysis from 2010 to 2023.
    PLoS One. 2026;21:e0344419.
    PubMed         Abstract available
    
    
93. WILSON D, Diji AK, Marfo R, Amoh P, et al
    Correction: Dietary adherence among persons with type 2 diabetes: A concurrent mixed methods study.
    PLoS One. 2026;21:e0344783.
    PubMed         Abstract available
    
    
94. TINA FA, Ahmed H, Biswas HR
    Hemodynamic simulation in the aortic arch under anemic, diabetic, and healthy blood flow conditions using computational fluid dynamics.
    PLoS One. 2026;21:e0334297.
    PubMed         Abstract available
    
    
95. RETNAKARAN M, Lessa VL, Kramer CK
    Time restricted EAting for Type 2 diabetes and MEtabolic health: The TEA TIME trial study protocol.
    PLoS One. 2026;21:e0343494.
    PubMed         Abstract available
    
    
96. ZHANG F, Wei L, Liu Y, Yang G, et al
    Association between the lactate-to-albumin ratio and 28-day all-cause mortality in diabetic ketoacidosis patients: A retrospective cohort study utilizing the MIMIC-IV database.
    PLoS One. 2026;21:e0344767.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

97. ZHANG Y, Zhang S, Yang Y, Tao L, et al
    A wireless sweat sensing with a pH-based correlation model for continuous glucose monitoring and diabetes management during exercise.
    Proc Natl Acad Sci U S A. 2026;123:e2532127123.
    PubMed         Abstract available
    
    

    
    Retina

98. LIN CC, Cheng CK, Peng PH, Cheng SF, et al
    Real world practice of Artificial intelligence Diagnostic System for Diabetic Retinopathy in Taiwan.
    Retina. 2026 Mar 12. doi: 10.1097/IAE.0000000000004826.
    PubMed         Abstract available
    
    

    
    Transplant Proc

99. NICOLUZZI A, Goncalves LDC, Yamaoka LMM, Nicoluzzi JE, et al
    Liver Transplantation From a Recently Transplanted Multiorgan Patient: a Case Report.
    Transplant Proc. 2026 Feb 6:S0041-1345(26)00030.
    PubMed         Abstract available
    
    
100. KABEI K, Iwai T, Kosoku A, Nishide S, et al
     A Case of Bariatric Surgery for a Japanese Kidney Transplant Recipient With Diabetes Mellitus: A Case Report.
     Transplant Proc. 2023;55:1910-1912.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum